Cognitive Behavioral Therapy for COPD (CLIMB)
Primary Purpose
COPD, Depression
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CLIMB (COPD Lifestyle, Mood, and Behavior)
Sponsored by

About this trial
This is an interventional treatment trial for COPD
Eligibility Criteria
Inclusion Criteria:
- COPD (FEV1/FVC < 70% & FEV1 <80%; current or past smoking >10pack-years)
- Depressed (PHQ-9 >=10)
- Ability to speak, read and write English
- Willingness to use computer or study-issued tablet device
Exclusion Criteria:
- Current non-nicotine substance abuse or dependence
- Psychotic disorder
- Active suicide ideation with intent and plan
- Alzheimer's/dementia
- Currently receiving any psychotherapy
Sites / Locations
- University of Washington
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
CLIMB (COPD Lifestyle, Mood, and Behavior)
Control
Arm Description
Counseling sessions for COPD and depression
Usual Care
Outcomes
Primary Outcome Measures
Depressive Symptoms
Personal Health Questionnaire-9
Secondary Outcome Measures
Dyspnea Intensity and Distress
Chronic Respiratory Questionnaire, Shortness of Breath Questionnaire, Dyspnea Management Questionnaire
Fatigue
Chronic Respiratory Questionnaire
Anxiety
Hospital Anxiety and Depression Scale
Physical Activity
Accelerometry (Stepwatch)
Quality of Life
Chronic Respiratory Questionnaire and Medical Outcomes Short Form-36
Full Information
NCT ID
NCT01694628
First Posted
September 24, 2012
Last Updated
September 27, 2021
Sponsor
University of Washington
Collaborators
Icahn School of Medicine at Mount Sinai
1. Study Identification
Unique Protocol Identification Number
NCT01694628
Brief Title
Cognitive Behavioral Therapy for COPD
Acronym
CLIMB
Official Title
Psychosocial-Behavioral Therapy for Patients With Advanced COPD and Depression
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
September 2012 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
October 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
Icahn School of Medicine at Mount Sinai
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study in patients with advanced COPD and depression is twofold:
Determine the feasibility and acceptability of a 6-session e-counseling intervention
Determine the efficacy of the e-counseling intervention on depressive symptoms
We hypothesize that patients who participate in e-counseling will have improved depressive symptoms compared to patients receiving usual care at 8 weeks.
Detailed Description
Chronic obstructive pulmonary disease (COPD) is the third leading cause of the death in the US. Although COPD is mostly preventable, there is no cure. Thus, care of patients with COPD is primarily focused on symptom palliation with the goal of improving quality of life for both patients and their families. These goals are highly consistent with core principles of palliative care. Dyspnea is the most distressing symptom for patients. Even optimal disease-directed treatment provides only partial relief from dyspnea. Depression is consistently associated with worse dyspnea, but the mechanisms underlying this relationship are poorly understood. Since existing treatment for dyspnea has only limited success and there is evidence that treating depression alleviates pain, we propose that by improving mood, we may be more successful in alleviating dyspnea. Psychosocial-behavioral therapy (PBT) which is focused on increasing pleasant events and improving problem solving skills has been shown to have immediate and sustained effects on depressive symptoms in patients with dementia and post-stroke holds tremendous promise for efficacy in advanced COPD. Testing the use of novel technologies to provide efficacious interventions such as PBT to patients with advanced disease is critical for translational palliative care research
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COPD, Depression
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
18 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CLIMB (COPD Lifestyle, Mood, and Behavior)
Arm Type
Experimental
Arm Description
Counseling sessions for COPD and depression
Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual Care
Intervention Type
Behavioral
Intervention Name(s)
CLIMB (COPD Lifestyle, Mood, and Behavior)
Intervention Description
Cognitive Behavioral Therapy delivered to patients via telephone aimed to improve mood and decrease depressive symptoms.
Primary Outcome Measure Information:
Title
Depressive Symptoms
Description
Personal Health Questionnaire-9
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Dyspnea Intensity and Distress
Description
Chronic Respiratory Questionnaire, Shortness of Breath Questionnaire, Dyspnea Management Questionnaire
Time Frame
8 weeks
Title
Fatigue
Description
Chronic Respiratory Questionnaire
Time Frame
8 weeks
Title
Anxiety
Description
Hospital Anxiety and Depression Scale
Time Frame
8 weeks
Title
Physical Activity
Description
Accelerometry (Stepwatch)
Time Frame
8 weeks
Title
Quality of Life
Description
Chronic Respiratory Questionnaire and Medical Outcomes Short Form-36
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
COPD (FEV1/FVC < 70% & FEV1 <80%; current or past smoking >10pack-years)
Depressed (PHQ-9 >=10)
Ability to speak, read and write English
Willingness to use computer or study-issued tablet device
Exclusion Criteria:
Current non-nicotine substance abuse or dependence
Psychotic disorder
Active suicide ideation with intent and plan
Alzheimer's/dementia
Currently receiving any psychotherapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lynn F Reinke, PhD, RN
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Cognitive Behavioral Therapy for COPD
We'll reach out to this number within 24 hrs